SOGECLAIR (ALSOG.PA) Fundamental Analysis & Valuation

EPA:ALSOG • FR0000065864

Current stock price

33.6 EUR
0 (0%)
Last:

This ALSOG.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. ALSOG.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALSOG was profitable.
  • ALSOG had a positive operating cash flow in the past year.
  • In the past 5 years ALSOG has always been profitable.
  • Each year in the past 5 years ALSOG had a positive operating cash flow.
ALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.85%, ALSOG is in line with its industry, outperforming 42.86% of the companies in the same industry.
  • The Return On Equity of ALSOG (11.09%) is comparable to the rest of the industry.
  • ALSOG has a Return On Invested Capital of 10.01%. This is in the better half of the industry: ALSOG outperforms 62.50% of its industry peers.
Industry RankSector Rank
ROA 3.85%
ROE 11.09%
ROIC 10.01%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSOG.PA Yearly ROA, ROE, ROICALSOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

  • The Profit Margin of ALSOG (3.56%) is worse than 66.07% of its industry peers.
  • ALSOG's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ALSOG (6.36%) is worse than 71.43% of its industry peers.
  • ALSOG's Operating Margin has improved in the last couple of years.
  • ALSOG's Gross Margin of 59.67% is amongst the best of the industry. ALSOG outperforms 89.29% of its industry peers.
  • ALSOG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.36%
PM (TTM) 3.56%
GM 59.67%
OM growth 3Y22.34%
OM growth 5YN/A
PM growth 3Y34.5%
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5Y1.63%
ALSOG.PA Yearly Profit, Operating, Gross MarginsALSOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ALSOG.PA Health Analysis

2.1 Basic Checks

  • ALSOG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • ALSOG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALSOG.PA Yearly Shares OutstandingALSOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
ALSOG.PA Yearly Total Debt VS Total AssetsALSOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • ALSOG has an Altman-Z score of 2.72. This is not the best score and indicates that ALSOG is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ALSOG has a Altman-Z score (2.72) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of ALSOG is 1.55, which is an excellent value as it means it would take ALSOG, only 1.55 years of fcf income to pay off all of its debts.
  • ALSOG has a Debt to FCF ratio of 1.55. This is amongst the best in the industry. ALSOG outperforms 85.71% of its industry peers.
  • ALSOG has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ALSOG (0.36) is better than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 1.55
Altman-Z 2.72
ROIC/WACC1.16
WACC8.61%
ALSOG.PA Yearly LT Debt VS Equity VS FCFALSOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

2.3 Liquidity

  • ALSOG has a Current Ratio of 1.78. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.78, ALSOG is in the better half of the industry, outperforming 73.21% of the companies in the same industry.
  • ALSOG has a Quick Ratio of 1.55. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 1.55, ALSOG belongs to the best of the industry, outperforming 83.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.55
ALSOG.PA Yearly Current Assets VS Current LiabilitesALSOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALSOG.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 29.07% over the past year.
  • Measured over the past years, ALSOG shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.55% on average per year.
  • The Revenue has been growing slightly by 2.08% in the past year.
  • The Revenue has been growing slightly by 5.43% on average over the past years.
EPS 1Y (TTM)29.07%
EPS 3Y42.55%
EPS 5YN/A
EPS Q2Q%12.82%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y5.91%
Revenue growth 5Y5.43%
Sales Q2Q%2.3%

3.2 Future

  • Based on estimates for the next years, ALSOG will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.48% on average per year.
  • Based on estimates for the next years, ALSOG will show a small growth in Revenue. The Revenue will grow by 5.23% on average per year.
EPS Next Y13.02%
EPS Next 2Y14.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.65%
Revenue Next 2Y5.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALSOG.PA Yearly Revenue VS EstimatesALSOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSOG.PA Yearly EPS VS EstimatesALSOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

7

4. ALSOG.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.97, the valuation of ALSOG can be described as rather expensive.
  • 98.21% of the companies in the same industry are more expensive than ALSOG, based on the Price/Earnings ratio.
  • ALSOG is valuated rather cheaply when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
  • ALSOG is valuated correctly with a Price/Forward Earnings ratio of 12.94.
  • Based on the Price/Forward Earnings ratio, ALSOG is valued cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.68, ALSOG is valued a bit cheaper.
Industry RankSector Rank
PE 17.97
Fwd PE 12.94
ALSOG.PA Price Earnings VS Forward Price EarningsALSOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than ALSOG, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ALSOG is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.51
EV/EBITDA 5.83
ALSOG.PA Per share dataALSOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of ALSOG may justify a higher PE ratio.
  • ALSOG's earnings are expected to grow with 14.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.38
PEG (5Y)N/A
EPS Next 2Y14.48%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ALSOG.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.82%, ALSOG has a reasonable but not impressive dividend return.
  • ALSOG's Dividend Yield is rather good when compared to the industry average which is at 0.88. ALSOG pays more dividend than 98.21% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ALSOG pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.82%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
ALSOG.PA Yearly Dividends per shareALSOG.PA Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • ALSOG pays out 51.33% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP51.33%
EPS Next 2Y14.48%
EPS Next 3YN/A
ALSOG.PA Yearly Income VS Free CF VS DividendALSOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 0 10M -10M 20M
ALSOG.PA Dividend Payout.ALSOG.PA Dividend Payout, showing the Payout Ratio.ALSOG.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ALSOG.PA Fundamentals: All Metrics, Ratios and Statistics

SOGECLAIR

EPA:ALSOG (4/29/2026, 7:00:00 PM)

33.6

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Industry Strength63.51
Industry Growth78.67
Earnings (Last)03-11
Earnings (Next)04-29
Inst Owners6.1%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap107.52M
Revenue(TTM)160.28M
Net Income(TTM)5.71M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.82%
Yearly Dividend0.94
Dividend Growth(5Y)N/A
DP51.33%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.97
Fwd PE 12.94
P/S 0.67
P/FCF 6.51
P/OCF 5.73
P/B 2.09
P/tB 3.52
EV/EBITDA 5.83
EPS(TTM)1.87
EY5.57%
EPS(NY)2.6
Fwd EY7.73%
FCF(TTM)5.16
FCFY15.36%
OCF(TTM)5.86
OCFY17.44%
SpS50.09
BVpS16.09
TBVpS9.54
PEG (NY)1.38
PEG (5Y)N/A
Graham Number26.0225 (-22.55%)
Profitability
Industry RankSector Rank
ROA 3.85%
ROE 11.09%
ROCE 11.41%
ROIC 10.01%
ROICexc 13.51%
ROICexgc 19.77%
OM 6.36%
PM (TTM) 3.56%
GM 59.67%
FCFM 10.31%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y22.34%
OM growth 5YN/A
PM growth 3Y34.5%
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5Y1.63%
F-Score8
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 1.55
Debt/EBITDA 0.99
Cap/Depr 25.86%
Cap/Sales 1.39%
Interest Coverage 7.25
Cash Conversion 99.53%
Profit Quality 289.1%
Current Ratio 1.78
Quick Ratio 1.55
Altman-Z 2.72
F-Score8
WACC8.61%
ROIC/WACC1.16
Cap/Depr(3y)32.48%
Cap/Depr(5y)229.44%
Cap/Sales(3y)1.21%
Cap/Sales(5y)2.26%
Profit Quality(3y)253.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.07%
EPS 3Y42.55%
EPS 5YN/A
EPS Q2Q%12.82%
EPS Next Y13.02%
EPS Next 2Y14.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.08%
Revenue growth 3Y5.91%
Revenue growth 5Y5.43%
Sales Q2Q%2.3%
Revenue Next Year5.65%
Revenue Next 2Y5.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.83%
EBIT growth 3Y29.57%
EBIT growth 5YN/A
EBIT Next Year110.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8%
FCF growth 3YN/A
FCF growth 5Y-5.5%
OCF growth 1Y10.07%
OCF growth 3Y80.31%
OCF growth 5Y-6.21%

SOGECLAIR / ALSOG.PA Fundamental Analysis FAQ

What is the fundamental rating for ALSOG stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALSOG.PA.


What is the valuation status of SOGECLAIR (ALSOG.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to SOGECLAIR (ALSOG.PA). This can be considered as Undervalued.


How profitable is SOGECLAIR (ALSOG.PA) stock?

SOGECLAIR (ALSOG.PA) has a profitability rating of 6 / 10.


What is the financial health of SOGECLAIR (ALSOG.PA) stock?

The financial health rating of SOGECLAIR (ALSOG.PA) is 6 / 10.


Can you provide the dividend sustainability for ALSOG stock?

The dividend rating of SOGECLAIR (ALSOG.PA) is 5 / 10 and the dividend payout ratio is 51.33%.